Kallikreins are serine protease enzymes with various physiological functions. Kallikreins are associated with carcinogenesis and have the potential to be novel biomarkers for cancer. KLK1 (molecular weight28-32 kDa), also called stratum corneum tryptic enzyme, is one of the fifteen members of the kallikrein subfamily located in a cluster on chromosome 19. The enzyme KLK1 is functionally conserved in its ability to release the vasoactive peptide Lys-Bradykinin from low molecular weight kininogen. Kallikrein-1 is encoded by the gene of the same name on chromosome 19q13.33.
Human kallikrein-1 is an active protein enzyme found in saliva, pancreatic juice and urine that catalyzes the proteolysis of bradykininogen to bradykinin.
Kallikrein-1, which comes from humans or pigs, has long been used as a drug, especially for the treatment of mild to moderate hypertension and occlusion of cerebral and surrounding blood vessels.